A C Apple1, K L Possin2, G Satris2, E Johnson2, J M Lupo1, A Jakary1, K Wong2, D A C Kelley3, G A Kang2, S J Sha2, J H Kramer2, M D Geschwind2, S J Nelson1, C P Hess4. 1. From the Departments of Radiology and Biomedical Imaging (A.C.A., J.M.L., A.J., S.J.N., C.P.H.). 2. Neurology (K.L.P., G.S., E.J., K.W., G.A.K., S.J.S., J.H.K., M.D.G.), University of California, San Francisco. 3. GE Healthcare (D.A.C.K.), Global Applied Sciences Laboratory, Menlo Park, California. 4. From the Departments of Radiology and Biomedical Imaging (A.C.A., J.M.L., A.J., S.J.N., C.P.H.) Christopher.Hess@ucsf.edu.
Abstract
BACKGROUND AND PURPOSE: In vivo MR imaging and postmortem neuropathologic studies have demonstrated elevated iron concentration and atrophy within the striatum of patients with Huntington disease, implicating neuronal loss and iron accumulation in the pathogenesis of this neurodegenerative disorder. We used 7T MR imaging to determine whether quantitative phase, a measurement that reflects both iron content and tissue microstructure, is altered in subjects with premanifest Huntington disease. MATERIALS AND METHODS: Local field shift, calculated from 7T MR phase images, was quantified in 13 subjects with premanifest Huntington disease and 13 age- and sex-matched controls. All participants underwent 3T and 7T MR imaging, including volumetric T1 and 7T gradient recalled-echo sequences. Local field shift maps were created from 7T phase data and registered to caudate ROIs automatically parcellated from the 3T T1 images. Huntington disease-specific disease burden and neurocognitive and motor evaluations were also performed and compared with local field shift. RESULTS: Subjects with premanifest Huntington disease had smaller caudate volume and higher local field shift than controls. A significant correlation between these measurements was not detected, and prediction accuracy for disease state improved with inclusion of both variables. A positive correlation between local field shift and genetic disease burden was also found, and there was a trend toward significant correlations between local field shift and neurocognitive tests of working memory and executive function. CONCLUSIONS: Subjects with premanifest Huntington disease exhibit differences in 7T MR imaging phase within the caudate nuclei that correlate with genetic disease burden and trend with neurocognitive assessments. Ultra-high-field MR imaging of quantitative phase may be a useful approach for monitoring neurodegeneration in premanifest Huntington disease.
BACKGROUND AND PURPOSE: In vivo MR imaging and postmortem neuropathologic studies have demonstrated elevated iron concentration and atrophy within the striatum of patients with Huntington disease, implicating neuronal loss and iron accumulation in the pathogenesis of this neurodegenerative disorder. We used 7T MR imaging to determine whether quantitative phase, a measurement that reflects both iron content and tissue microstructure, is altered in subjects with premanifest Huntington disease. MATERIALS AND METHODS: Local field shift, calculated from 7T MR phase images, was quantified in 13 subjects with premanifest Huntington disease and 13 age- and sex-matched controls. All participants underwent 3T and 7T MR imaging, including volumetric T1 and 7T gradient recalled-echo sequences. Local field shift maps were created from 7T phase data and registered to caudate ROIs automatically parcellated from the 3T T1 images. Huntington disease-specific disease burden and neurocognitive and motor evaluations were also performed and compared with local field shift. RESULTS: Subjects with premanifest Huntington disease had smaller caudate volume and higher local field shift than controls. A significant correlation between these measurements was not detected, and prediction accuracy for disease state improved with inclusion of both variables. A positive correlation between local field shift and genetic disease burden was also found, and there was a trend toward significant correlations between local field shift and neurocognitive tests of working memory and executive function. CONCLUSIONS: Subjects with premanifest Huntington disease exhibit differences in 7T MR imaging phase within the caudate nuclei that correlate with genetic disease burden and trend with neurocognitive assessments. Ultra-high-field MR imaging of quantitative phase may be a useful approach for monitoring neurodegeneration in premanifest Huntington disease.
Authors: E H Aylward; A M Codori; A Rosenblatt; M Sherr; J Brandt; O C Stine; P E Barta; G D Pearlson; C A Ross Journal: Mov Disord Date: 2000-05 Impact factor: 10.338
Authors: H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Vasanth Pappu; Bruce Fischl; Doug Greve; Nathanael Hevelone; Steven M Hersch Journal: Brain Date: 2008-03-12 Impact factor: 13.501
Authors: H D Rosas; J Goodman; Y I Chen; B G Jenkins; D N Kennedy; N Makris; M Patti; L J Seidman; M F Beal; W J Koroshetz Journal: Neurology Date: 2001-09-25 Impact factor: 9.910
Authors: Jane S Paulsen; Michael Hayden; Julie C Stout; Douglas R Langbehn; Elizabeth Aylward; Christopher A Ross; Mark Guttman; Martha Nance; Karl Kieburtz; David Oakes; Ira Shoulson; Elise Kayson; Shannon Johnson; Elizabeth Penziner Journal: Arch Neurol Date: 2006-06
Authors: Randy L Buckner; Denise Head; Jamie Parker; Anthony F Fotenos; Daniel Marcus; John C Morris; Abraham Z Snyder Journal: Neuroimage Date: 2004-10 Impact factor: 6.556
Authors: Kathryn E Hammond; Janine M Lupo; Duan Xu; Meredith Metcalf; Douglas A C Kelley; Daniel Pelletier; Susan M Chang; Pratik Mukherjee; Daniel B Vigneron; Sarah J Nelson Journal: Neuroimage Date: 2007-11-07 Impact factor: 6.556
Authors: Nhat Trung Doan; Simon J A van den Bogaard; Eve M Dumas; Andrew G Webb; Mark A van Buchem; Raymund A C Roos; Jeroen van der Grond; Johan H C Reiber; Julien Milles Journal: J Magn Reson Imaging Date: 2013-05-30 Impact factor: 4.813
Authors: J M G van Bergen; J Hua; P G Unschuld; I A L Lim; C K Jones; R L Margolis; C A Ross; P C M van Zijl; X Li Journal: AJNR Am J Neuroradiol Date: 2015-12-17 Impact factor: 3.825
Authors: Hosung Kim; Ji-Hoon Kim; Katherine L Possin; Joseph Winer; Michael D Geschwind; Duan Xu; Christopher P Hess Journal: Brain Imaging Behav Date: 2017-10 Impact factor: 3.978
Authors: Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind Journal: Semin Neurol Date: 2017-12-05 Impact factor: 3.420
Authors: Danielle A Simmons; Brian D Mills; Robert R Butler Iii; Jason Kuan; Tyne L M McHugh; Carolyn Akers; James Zhou; Wassim Syriani; Maged Grouban; Michael Zeineh; Frank M Longo Journal: Neurotherapeutics Date: 2021-03-30 Impact factor: 7.620
Authors: Katerina Akassoglou; Dritan Agalliu; Christopher J Chang; Dimitrios Davalos; Jaime Grutzendler; Elizabeth M C Hillman; Baljit S Khakh; David Kleinfeld; Dorian B McGavern; Sarah J Nelson; Berislav V Zlokovic Journal: Front Neurosci Date: 2016-02-22 Impact factor: 4.677